Listed

Adicet Bio, Inc.

ACETNasdaqCIK 1720580HealthcareFiscal year ends Dec 26

Reports and events: 223 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Adicet Bio, Inc., Reports and events
FiledFormWhat it isAccession number
2024-08-1307:04 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-095745
2024-08-1307:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-095744
2024-07-0807:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-24-081943
2024-06-2407:02 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-076460
2024-06-0716:02 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-24-070568
2024-06-0507:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-24-069067
2024-05-1416:05 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-059507
2024-05-1416:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-059496
2024-05-1006:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-24-057429
2024-04-2317:03 ETDEF 14AProxy statementPeriod 2024-04-230000950170-24-047034
2024-04-2216:31 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-046459
2024-03-2216:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000950170-24-035366
2024-03-2116:31 ETSC 13D/AOwnership report, active investor, amended0000947871-24-000300
2024-03-1916:15 ET10-KAnnual reportPeriod 2023-12-310000950170-24-033482
2024-03-1916:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-033476
2024-02-0716:31 ETSC 13D/AOwnership report, active investor, amended0001193125-24-026734
2024-01-2916:55 ETSC 13D/AOwnership report, active investor, amended0000947871-24-000074
2024-01-2416:34 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-007011
2024-01-1607:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-24-004403
2024-01-0407:17 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-001490
2023-11-1316:42 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-063062
2023-11-0816:14 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-061128
2023-11-0816:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-061121
2023-08-0916:20 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-040631
2023-08-0916:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-040617
2023-07-1108:32 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-032449
2023-06-2916:30 ETSC 13D/AOwnership report, active investor, amended0000947871-23-000710
2023-06-2616:02 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-029851
2023-06-0516:52 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000950170-23-026406
2023-06-0517:45 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-23-026198
2023-05-1806:02 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-022865
2023-05-0916:17 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019700
2023-05-0916:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-019685
2023-04-1816:30 ETDEF 14AProxy statementPeriod 2022-12-310000950170-23-013294
2023-03-1516:07 ET10-KAnnual reportPeriod 2022-12-310000950170-23-008130
2023-03-1516:04 ET8-K2.02 Results of operations0000950170-23-008122
2023-03-1015:46 ET8-K7.01 Regulation FD disclosure0000950170-23-007252
2022-12-1206:03 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-026329
2022-12-0816:09 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000950170-22-026232
2022-11-1017:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-024573
2022-11-0816:16 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-023230
2022-11-0816:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-023224
2022-11-0309:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-021598
2022-10-0508:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-019282
2022-08-1117:00 ETSC 13D/AOwnership report, active investor, amended0001193125-22-218665
2022-08-1007:09 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016254
2022-08-1007:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-016250
2022-06-2117:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000950170-22-011916
2022-06-0616:01 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-011219
2022-06-0316:32 ET8-K5.07 Shareholder vote results0000950170-22-011172

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:00 ET. Listed shows no prices and gives no investment advice.